valueequityanalysis.com

Independent, business-by-business valuations built from company filings — owner earnings, a ten-year outlook, and a bear / base / bull range. Search a ticker to see our estimate of what the business is worth.

Not investment advice. We are not registered investment advisers, and the people behind this site may hold or trade positions in companies analyzed here. Full disclosures.

PHOTRONICS INC (PLAB) stock intrinsic value fair value estimate & owner earnings analysis

Margin of safety$15.00 ComplexityAverage Updated
$17.78 $33.50
bear $17.78 base $27.43 bull $33.50 margin of safety $15.00 market price* $27.52
Photronics makes photomasks, the master templates that chipmakers and flat-panel display makers use to print circuit patterns, and is one of a handful of independent suppliers at scale alongside Toppan, Dai Nippon Printing and Hoya. Masks are custom, made to order, and replaced whenever a customer launches a new design, so demand tracks the number of new chip and display designs rather than wafer volume. Revenue roughly doubled from $451 million in fiscal 2017 to $892 million in 2023 as new plants in Xiamen and Hefei, China, and expanded Taiwan capacity came on line, then eased to $849 million in fiscal 2025; the first nine months of fiscal 2026 were $651 million, about 3% ahead of last year. Sales are concentrated in Asia (Taiwan, China and South Korea together are well over half), the five largest customers take about half of revenue, and one large customer that is related to an executive officer bought $137 million in 2025. Two features of the accounts drive the valuation. First, the Taiwan and China businesses are joint ventures in which Photronics owns 50.01%; their profit and cash are consolidated in full, but about 29% of group profit belongs to the partners. We count only Photronics' share. Second, this is a capital-hungry business: capital spending ran $131 million in 2023 and 2024, jumped to $188 million in fiscal 2025, and is planned at about $330 million in fiscal 2026 for new high-end and mainstream tools, including the Allen, Texas and Korean expansions. Because revenue was flat to down in 2024 and 2025, we treat all of that spending as the cost of staying competitive rather than growth, which is why cash earnings fall well below reported profit (diluted EPS of $2.28 in 2025). On that basis, Photronics' share of owner earnings per share was $0.94, $0.77, $1.91, $1.63, $1.53 and $0.75 over fiscal 2020 to 2025. We measure from 2020 because the China plants transformed the business that year; the median of those six years is about $1.24 a share. Interest is negligible, since debt has been repaid down to almost nothing. The most recent full year was weak (owner earnings fell about 51%), but the fiscal 2026 interim filings already show $0.93 a share earned in the nine months to August 2, 2026, so year one of the base case is set at $1.00, which allows for heavy fourth-quarter equipment payments. From year two the base case returns to the $1.24 normal level and holds it: masks are a structural need of every new chip design and the company has earned at about this level through recent conditions, but we credit no growth, because growth here has come from new plants and share gains, which are not yet in the bag. On that path the business is worth about $1.21 billion, or $20.60 a share. The bear case includes a full semiconductor downturn of the 2009 kind, when Photronics' revenue fell about 15% and its high fixed costs turned that into a far larger drop in cash. Owner earnings go from $0.90 to $0.15 and then to a loss of $0.30 a share in the trough year while committed equipment payments continue, then recover only to $0.75 a share for good, the level of 2016 to 2021, reflecting price competition from Chinese domestic mask makers in mainstream products and a capital budget that stays elevated. That business is worth about $640 million, or $10.95 a share. The bull case has the new capacity filling as planned, with owner earnings rising to $1.35 in year two and settling at $1.65, the average of the strong 2022 to 2024 years, worth about $1.57 billion, or $26.67 a share. What the company owes is close to nothing; what it holds is substantial. At August 2, 2026 it had $549.5 million of cash and $123.3 million of short-term investments. About 60% of the cash sits in the Taiwan and China joint ventures, half of which belongs to the partners, so we remove about $202 million for them, keep $50 million as working cash, and allow $20 million for taxes and withholding on bringing money out of Asia. That leaves about $401 million, or $6.83 a share, belonging to shareholders. Adding it to each case: bear $17.78, base $27.43, bull $33.50 a share. The previous analysis used a different method, so its figures are not directly comparable; the main business change since then is that fiscal 2026 results so far are tracking better than fiscal 2025. On the margin-of-safety price: we are moderately confident in the earnings level, because six years of results since the China plants opened cluster between $0.75 and $1.91 a share, but the spread is wide and depends heavily on how much the company must keep spending on tools. The worst plausible outcome no case models is a military or trade conflict that cuts off the Taiwan and China plants, which produce roughly half of revenue; the company has no debt, so it would survive, but the remaining US, Korean and European plants plus the cash would likely be worth only in the low teens a share. The things we are most likely wrong about are the permanent capital budget (if $250 million a year is the new normal, owner earnings stay near $0.75 and the shares are worth near the bear case) and Chinese pricing in mainstream masks. During the holding period, the business pays no dividend but has been buying back stock ($97 million in fiscal 2025) and earns roughly $1 a share for owners. At $15 a share, the bear value of about $18 provides a cushion even through a downturn, and a move to base value within about three years implies more than 20% a year; above that, a downturn arriving early would leave the cases short of the target. The margin-of-safety price is $15.
Fiscal yearOwner's earningsMethodology
2025 $0.75 ▼
Recomputed on current basis (replaces prior CFO-capex-SBC formula). OE = CFO - dWC - SBC - maintenance capex, then x parent share. CFO=$247.8M; working-capital cash effect=$-16.3M (removed); SBC=$13.4M; capex=$188.1M, growth capex=$0 (revenue declined), maintenance capex=$188.1M; consolidated OE=$62.5M; x parent share of profit (NI attributable 136.4/consolidated 190.2 = 71.7%, removing 49.99% minority interests in Taiwan and China JVs) = $44.8M; diluted shares=59.920M; OE/sh=$0.75. Check: NI+D&A+SBC+deferred tax = $263.7M vs CFO ex-WC $264.1M (gap <5%). Source: FY2025 10-K, accession 0001140361-25-045801.
2024 $1.53 ▼
Recomputed on current basis (replaces prior CFO-capex-SBC formula). OE = CFO - dWC - SBC - maintenance capex, then x parent share. CFO=$261.4M; working-capital cash effect=$-17.7M (removed); SBC=$13.9M; capex=$130.9M, growth capex=$0 (revenue declined), maintenance capex=$130.9M; consolidated OE=$134.3M; x parent share of profit (NI attributable 130.7/consolidated 183.8 = 71.1%, removing 49.99% minority interests in Taiwan and China JVs) = $95.5M; diluted shares=62.391M; OE/sh=$1.53. Check: NI+D&A+SBC+deferred tax = $278.8M vs CFO ex-WC $279.2M (gap <5%). Source: FY2025 10-K, accession 0001140361-25-045801 (comparatives).
2023 $1.63 ▼
Recomputed on current basis (replaces prior CFO-capex-SBC formula). OE = CFO - dWC - SBC - maintenance capex, then x parent share. CFO=$302.2M; working-capital cash effect=$14.6M (removed); SBC=$8.0M; capex=$131.3M, growth capex = 17.41% avg capex/revenue (FY2016-25) x revenue change $67.5M = $11.8M, maintenance capex=$119.5M; consolidated OE=$160.0M; x parent share of profit (NI attributable 125.5/consolidated 199.6 = 62.9%, removing 49.99% minority interests in Taiwan and China JVs) = $100.6M; diluted shares=61.755M; OE/sh=$1.63. Check: NI+D&A+SBC+deferred tax = $287.2M vs CFO ex-WC $287.5M (gap <5%). Source: FY2025 10-K, accession 0001140361-25-045801 (comparatives).
2022 $1.91 ▼
Recomputed on current basis (replaces prior CFO-capex-SBC formula). OE = CFO - dWC - SBC - maintenance capex, then x parent share. CFO=$275.2M; working-capital cash effect=$8.5M (removed); SBC=$6.3M; capex=$112.3M, growth capex = 17.41% avg capex/revenue (FY2016-25) x revenue change $160.8M = $28.0M, maintenance capex=$84.3M; consolidated OE=$176.0M; x parent share of profit (NI attributable 118.8/consolidated 179.2 = 66.3%, removing 49.99% minority interests in Taiwan and China JVs) = $116.7M; diluted shares=61.189M; OE/sh=$1.91. Check: NI+D&A+SBC+deferred tax = $266.3M vs CFO ex-WC $266.7M (gap <5%). Source: FY2024 10-K, accession 0001140361-24-049881 (comparatives).
2021 $0.77 ▼
Recomputed on current basis (replaces prior CFO-capex-SBC formula). OE = CFO - dWC - SBC - maintenance capex, then x parent share. CFO=$150.8M; working-capital cash effect=$-21.7M (removed); SBC=$5.3M; capex=$109.1M, growth capex = 17.41% avg capex/revenue (FY2016-25) x revenue change $54.1M = $9.4M, maintenance capex=$99.7M; consolidated OE=$67.4M; x parent share of profit (NI attributable 55.4/consolidated 78.8 = 70.4%, removing 49.99% minority interests in Taiwan and China JVs) = $47.4M; diluted shares=61.999M; OE/sh=$0.77. Check: NI+D&A+SBC+deferred tax = $169.6M vs CFO ex-WC $172.4M (gap <5%). Source: FY2021 10-K, accession 0001140361-21-042251.
2020 $0.94 ▼
Recomputed on current basis (replaces prior CFO-capex-SBC formula). OE = CFO - dWC - SBC - maintenance capex, then x parent share. CFO=$143.0M; working-capital cash effect=$4.4M (removed); SBC=$4.9M; capex=$70.8M, growth capex = 17.41% avg capex/revenue (FY2016-25) x revenue change $59.0M = $10.3M, maintenance capex=$60.5M; consolidated OE=$73.2M; x parent share of profit (NI attributable 33.8/consolidated 40.3 = 83.8%, removing 49.99% minority interests in Taiwan and China JVs) = $61.3M; diluted shares=65.470M; OE/sh=$0.94. Check: NI+D&A+SBC+deferred tax = $134.0M vs CFO ex-WC $138.6M (gap <5%). Source: FY2021 10-K, accession 0001140361-21-042251 (comparatives).
2019 -$0.59 ▼
Recomputed on current basis (replaces prior CFO-capex-SBC formula). OE = CFO - dWC - SBC - maintenance capex, then x parent share. CFO=$68.4M; working-capital cash effect=$-56.0M (removed); SBC=$3.7M; capex=$178.4M, growth capex = 17.41% avg capex/revenue (FY2016-25) x revenue change $15.4M = $2.7M, maintenance capex=$175.7M; consolidated OE=$-55.0M; x parent share of profit (NI attributable 29.8/consolidated 40.5 = 73.6%, removing 49.99% minority interests in Taiwan and China JVs) = $-40.5M; diluted shares=69.155M; OE/sh=$-0.59. Check: NI+D&A+SBC+deferred tax = $119.7M vs CFO ex-WC $124.4M (gap <5%). Source: FY2019 10-K, accession 0001140361-19-023041.
2018 $0.62 ▼
Recomputed on current basis (replaces prior CFO-capex-SBC formula). OE = CFO - dWC - SBC - maintenance capex, then x parent share. CFO=$130.6M; working-capital cash effect=$-17.9M (removed); SBC=$3.2M; capex=$92.6M, growth capex = 17.41% avg capex/revenue (FY2016-25) x revenue change $84.6M = $14.7M, maintenance capex=$77.9M; consolidated OE=$67.4M; x parent share of profit (NI attributable 42.1/consolidated 61.2 = 68.7%, removing 49.99% minority interests in Taiwan and China JVs) = $46.3M; diluted shares=74.821M; OE/sh=$0.62. Check: NI+D&A+SBC+deferred tax = $143.7M vs CFO ex-WC $148.5M (gap <5%). Source: FY2019 10-K, accession 0001140361-19-023041 (comparatives).
2017 $0.16 ▼
Recomputed on current basis (replaces prior CFO-capex-SBC formula). OE = CFO - dWC - SBC - maintenance capex, then x parent share. CFO=$96.8M; working-capital cash effect=$-16.3M (removed); SBC=$3.6M; capex=$92.0M, growth capex=$0 (revenue declined), maintenance capex=$92.0M; consolidated OE=$17.5M; x parent share of profit (NI attributable 13.1/consolidated 21.3 = 61.7%, removing 49.99% minority interests in Taiwan and China JVs) = $10.8M; diluted shares=69.288M; OE/sh=$0.16. Check: NI+D&A+SBC+deferred tax = $108.2M vs CFO ex-WC $113.1M (gap <5%). Source: FY2017 10-K, accession 0001140361-17-046903.
2016 $0.82 ▼
Recomputed on current basis (replaces prior CFO-capex-SBC formula). OE = CFO - dWC - SBC - maintenance capex, then x parent share. CFO=$122.1M; working-capital cash effect=$-7.5M (removed); SBC=$3.8M; capex=$50.1M, growth capex=$0 (revenue declined), maintenance capex=$50.1M; consolidated OE=$75.6M; x parent share of profit (NI attributable 46.2/consolidated 55.7 = 83.0%, removing 49.99% minority interests in Taiwan and China JVs) = $62.7M; diluted shares=76.354M; OE/sh=$0.82. Check: NI+D&A+SBC+deferred tax = $133.3M vs CFO ex-WC $129.6M (gap <5%). Source: FY2017 10-K, accession 0001140361-17-046903 (comparatives).

Owner's earnings per share by fiscal year, most recent first. Tap a row to see how that figure was calculated, including the source filing.

Sales geography
Taiwan, China, South Korea, United States (West - Idaho; South - Texas; Northeast - Connecticut), Europe (United Kingdom, Germany)
Historical growth strategy
Organic capacity expansion through new photomask plants placed next to customer fabs, often funded with local joint-venture partners (Taiwan with Micro Mask/PDMC, China with Xiamen and Hefei facilities) and government incentives, plus technology upgrades into higher-end IC and flat-panel masks; occasional bolt-on acquisitions of captive mask shops and steady share buybacks.
Chart analysis
A chartist would describe a long multi-year base in the teens through the 2010s, a strong breakout in 2022-2023 as earnings jumped, a peak near the low 30s in 2023, then a series of lower highs and a slide back toward the high teens and low 20s, with the stock repeatedly finding support in that band. The pattern reads as a range-bound cyclical: support around the high teens, resistance in the high 20s to low 30s, and no confirmed new uptrend until price clears the prior peak on volume.
Competitors

Companies we consider competitors of PLAB. Tap a ticker to open our analysis of that company in a new tab.

Circle of competence

We don't have circle of competence information for this company yet.